Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,210
Sort by:
Keratitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Keratitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Drugs In Development, 2021, provides an o...
August 2021
105 pages
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Drugs In Development, 2021, pro...
August 2021
57 pages
Osteoporosis (Musculoskeletal) - Drugs In Development, 2021
US$ 2,500.00
Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In Development, 2021, provi...
August 2021
401 pages
Pheochromocytoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Pheochromocytoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pheochromocytoma - Drugs In Development, 2021, prov...
August 2021
179 pages
Rabies (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Rabies (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Drugs In Development, 2021, provides an ov...
August 2021
108 pages
Retinoblastoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Retinoblastoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Drugs In Development, 2021, provides...
August 2021
84 pages
Stroke (Cardiovascular) - Drugs In Development, 2021
US$ 2,500.00
Stroke (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Drugs In Development, 2021, provides an overvi...
August 2021
862 pages
Ureter Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Ureter Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer - Drugs In Development, 2021, provides a...
August 2021
516 pages
Global Penicillin Drug Market by Product (Bulk and Dosage), Type (Aminopenicillin, Antipseudomonal Penicillin, Beta-lactamase Inhibitor, Natural Penicillin, and Penicillinase-resistant Penicillin), Manufacturing Process (Synthetic Process, Natural Process, and Semisynthetic Process), Mode of Delivery (Oral, Intramuscular, and Intravenous), and End User (Hospitals, Clinics, Research Institutes, and Others), Regional Forecasts 2021-2027
US$ 3,750.00
Global Penicillin Drug Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Penicillin is...
August 2021
200 pages
Global Oxytocic Pharmaceuticals Market Size study, By Type {Natural Oxytocin, Synthetic Oxytocin Derivative}, By Application {Abortion Induced Incomplete, Inevitable Abortion, Post-partum Hemorrhage, Labour Induction, Labour Arrest}, By End-use{Hospitals, Maternity Clinics}, Analysis Regional Forecasts 2021-2027
US$ 3,750.00
Global Oxytocic Pharmaceuticals Market reached USD XXX Billion in 2020. The Global Oxytocic Pharmaceuticals Market tends to grow by a CAGR of XX% in the 2021-2027 period. Oxytocin is a kind of drug us...
August 2021
200 pages
Global Vitamin Deficiency Treatment Market Size study, by Product (OTC Multivitamin Therapies, Single Vitamin Therapies, Vitamin A Supplements, Vitamin B Complex Supplements, Vitamin D Supplements and Others), End User (Pharmacy and Drugstores, Hospital Pharmacy, Online Drug Stores or Email Prescription Stores, Hypermarkets and Supermarkets), and Regional Forecasts 2021-2027
US$ 3,750.00
Global Vitamin Deficiency Treatment Market is valued approximately USD xx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2021-2027. Vi...
August 2021
200 pages
DNA Vaccines: Technologies and Global Markets
US$ 5,500.00
Report : The study’s scope includes DNA vaccine products that already are commercialized or likely to be in the next five years. Both human and animal health markets are studied. DNA vaccine delivery...
August 2021
113 pages
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...
July 2021
63 pages
Acne Vulgaris (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Acne Vulgaris (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Drugs In Development, 2021, provide...
July 2021
252 pages
Adenosine Receptor A3 - Drugs In Development, 2021
US$ 3,500.00
Adenosine Receptor A3 - Drugs In Development, 2021 SUMMARY Adenosine Receptor A3 (ADORA3) - The adenosine A3 receptor, also known as ADORA3, is an adenosine receptor. Adenosine A3 receptors are G prot...
July 2021
96 pages
Anal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Anal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Drugs In Development, 2021, provides an ov...
July 2021
813 pages
Blepharitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Blepharitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Drugs In Development, 2021, provides...
July 2021
79 pages
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8...
July 2021
63 pages
